It will therefore be interesting to determine, how FOXG1 protein levels in FOXG1 syndrome compare to FOXG1 protein levels in this study and whether glutamatergic and GABAergic NSPCs in the developing CNS display differential sensitivity to FOXG1 dosage. This evidence concerns the gene FOXG1 and Down syndrome.